Harmony Biosciences Holdings Inc

Harmony Biosciences insider trades reveal balanced strategy: CEO & COO buying, selling, and liquidating RSUs, indicating confidence and long‑term growth potential.

Harmony Biosciences CFO’s 3,746‑share sale under a 10b5‑1 plan is routine portfolio rebalancing, not a bearish signal for investors.